Skip to main content
Premium Trial:

Request an Annual Quote

Kailos PGxComplete

Kailos has launched PGxComplete, a comprehensive, full panel, gene-based test that the company is offering for $99 through November 30. The panel tests 20 different classes of medications to reveal how one's body responds to more than 50 types of medications, including antidepressants, opioids, HIV/AIDS treatment, and cancer therapy. The panel uses advanced technology that harnesses DNA sequencing and enables a more holistic view of a person's gene-based medical information, said Kailos in a statement. The company launched its first pharmacogenetics test (the Kailos test, formerly called Praxis) this past June. 

The Scan

Study Links Genetic Risk for ADHD With Alzheimer's Disease

A higher polygenic risk score for attention-deficit/hyperactivity disorder is also linked to cognitive decline and Alzheimer's disease, a new study in Molecular Psychiatry finds.

Study Offers Insights Into Role of Structural Variants in Cancer

A new study in Nature using cell lines shows that structural variants can enable oncogene activation.

Computer Model Uses Genetics, Health Data to Predict Mental Disorders

A new model in JAMA Psychiatry finds combining genetic and health record data can predict a mental disorder diagnosis before one is made clinically.

Study Tracks Off-Target Gene Edits Linked to Epigenetic Features

Using machine learning, researchers characterize in BMC Genomics the potential off-target effects of 19 computed or experimentally determined epigenetic features during CRISPR-Cas9 editing.